About Michael Silber

This author has not yet filled in any details.
So far Michael Silber has created 2507 blog entries.

Washington

Effective July 1, the Health Care Authority (HCA) Apple Health (Medicaid) added a new section to the audio-only behavioral health procedure code list for HCPCS codes billable for Reentry Targeted Case Management (rTCM). The revised list is posted online under "Billing guides and fee schedules"; click on "Reentry services". 

Also in Washington, Apple Health (Medicaid) announced changes to the State Maximum Allowable Costs (SMAC) list for the fee-for-service (FFS) Prescription Drug Program effective September 1. The full SMAC list can be found on the agency's Provider billing guides and fee schedules website under the Prescription Drug Program and applies to claims billed to FFS. 

Also in Washington, the Health Care Authority (HCA) Prescription Drug Program's third quarter Preferred Drug List has been posted. 

Also in Washington, the Health Care Authority (HCA) created a toolkit called Apple Health is Medicaid Communications Toolkit to assist providers, community leaders and advocates to help Washingtonians access care. 

Finally in Washington, in an effort to effort to help prevent opioid misuse and overdose deaths, Fred Meyer's 60 pharmacies partnered with the Health Care Authority (HCA) to provide free locking bags to patients to more safely store their opioid prescriptions. The HCA's Lock Up Your Meds safe storage program is part of the statewide Starts with One campaign to prevent opioid overdoses by increasing the safe use, storage and disposal of opioid prescriptions. 

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2025-07-11T08:58:00-04:00July 11, 2025|Washington|

West Virginia

The Secretary of State published a series of new proposed Board of Pharmacy rules that would implement legislation adopted in the 2025 session. Note that these include rules that allow pharmacist and technician licensing reciprocity and streamlining and that include a prohibition on dispensing abortion drugs and gender altering drugs for non-adults. Comments are due to the Board of Pharmacy by 5:00 pm on July 17.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2025-07-11T08:57:07-04:00July 11, 2025|West Virginia|

Wyoming

The Department of Health confirmed a case of measles in an unvaccinated child from Natrona County. This case is the first reported in the state since 2010.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2025-07-11T08:56:38-04:00July 11, 2025|Wyoming|

Alaska

The Board of Pharmacy is seeking input on a Just Culture Workplaces Survey. The results of this survey will be discussed by the board at the August 21 meeting. 

Also in Alaska, the Prescription Drug Monitoring Program (PDMP) will require the following data elements starting July 30: 

  • AIR09 & AIR10: Full first and last name of the dispensing pharmacist (no initials). 
  • DSP15: Pharmacist's state license number. 
  • PAT20: Species Code (01: Human, 02: Animal) – required. 
  • PAT23: Animal name – required if PAT20 is "02". 

Submissions with missing required fields will be rejected beginning on July 30. Please refer to the AK Data Submission Dispenser Guide v3.1 via the PMP Clearinghouse portal for detailed instructions. 

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2025-06-26T14:37:58-04:00June 26, 2025|Alaska|

Arkansas

NACDS sponsored the Arkansas Pharmacist Association's (APA) annual meeting. Gov. Sarah Huckaby Sanders (R) spoke about the importance of supporting our patients and their access to affordable healthcare. Chain and independent pharmacists thanked the Governor for her support of the profession and patients by protecting pharmacy access and ensuring patients across the state receive the care they deserve. 

Also in Arkansas, the Insurance Department issued Bulletin No. 9-2025, Arkansas 2025 Legislation report, summarizing newly adopted insurance laws. 

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2025-06-26T14:37:30-04:00June 26, 2025|Arkansas|

California

The Department of Health Care Service posted the following alerts on the Medi-Cal Rx Web Portal. As previously announced in the alert titled 60-Day Countdown: NCPDP Field 426-DQ Usual and Customary Charge Requirement, pharmacy providers submitting claims to Medi-Cal Rx with a date of service (DOS) on or after July 18 will be required to include their Usual and Customary (U&C) charge in NCPDP Field 426-DQ (Usual and Customary Charge). Claims submitted for the DOS on or after July 18 with a blank dollar amount or a value of $0.00 will be denied by Medi-Cal Rx with Reject Code DQ – M/I Usual and Customary Charge with the supplemental message "Resubmit claim with U&C charge in field 426-DQ."  

 Also in California, the Board of Pharmacy issued the following update regarding the California Medication Error Reporting (CAMER) system. An orientation webinar is being offered by the Institute for Safe Medication Practices (ISMP) at 1:00 pm Pacific on July 9. Also, medication errors that occur on or after September 1 must be reported to the CAMER system. For your convenience, here's a link to the CA Board of Pharmacy Medication Error Reporting System website hosted by ISMP. 

Business and Professions Code (BPC) section 4113.1 establishes requirements for a community pharmacy to report medication errors to an entity approved by the Board. The statute requiring medication error reporting by community pharmacies can be viewed at BPC section 4113.1. The Board approved ISMP, an ECRI Company, as the entity to receive and review medication error reports under BPC section 4113.1.  

Consistent with its commitment to keep licensees apprised of implementation activities related to the California Medication Error Reporting (CAMER) system, the Board is providing the following updates: 

  • ISMP will be holding an orientation webinar at 1:00 p.m. Pacific Time on July 9. Registration for the orientation webinar is available online. To view, go to FAQ and then "Will there be training or orientation sessions for how to use the reporting system and submit reports?". 
  • ISMP posted additional information related to reporting data elements. To view, go to FAQ and then "Which data elements will be built into the reporting system?". 

Also in California, the Office of Administrative Law approved the Board of Pharmacy's updated compounding regulations. The regulations describe the Board's requirements for nonsterile compounding, sterile compounding, hazardous drug and radiopharmaceutical preparations. 

The regulation is effective October 1. The Board will be releasing an updated policy statement regarding its expectations during the transition period. The Order of Adoption for the approved regulation regarding the compounding regulations has been posted.  

Also in California, the Board of Pharmacy proposes taking rulemaking action related to "Medication-Assisted Treatment Protocol". The proposed text is available for review on the Board's website. Written comments must be received by the Board no later than August 4 or must be received by the Board at the hearing, if one is scheduled. Inquiries or comments may be addressed to:  

  • Lori Martinez Address: 2720 Gateway Oaks Drive, Ste. 100, Sacramento, CA 95833; Phone: (916) 518-3100; Fax.: (916) 574-8618; or e-Mail Address: PharmacyRulemaking@dca.ca.gov   
  • The backup contact person is: Debbie Damoth Address: 2720 Gateway Oaks Drive, Ste. 100, Sacramento, CA 95833; Phone: (916) 518-3100; Fax.: (916) 574-8618; or e-Mail Address: PharmacyRulemaking@dca.ca.gov  

Finally in California, the Department of Health Care Services (DHCS) has been formally approved by the Centers for Medicare and Medicaid Services (CMS) to participate in the federal Cell and Gene Therapy (CGT) Access Model, with implementation effective July 1. This model is designed to improve access to high-cost, high-impact gene therapies for Medi-Cal members with complex conditions, starting with sickle cell disease (SCD). The initial therapies included in this model are Casgevy and Lyfgenia.  

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2025-06-26T14:36:52-04:00June 26, 2025|California|

Indiana

The Family and Social Services Administration (FSSA) Health Coverage Programs (IHCP) issued a Bulletin documenting requirements clarified for claims billed to Medicaid for dually eligible members. 

Also in Indiana, IHCP reminded providers about the benefits of submitting claims electronically and provided pharmacy updates approved by the Office of Medicaid Policy and Planning. 

Also in Indiana, IHCP announced that effective July 1, they will expand provider enrollment to include licensed pharmacists. This new provider specialty will allow eligible pharmacists to enroll as rendering providers linked to a group provider. Group providers may be reimbursed for evaluation and management (E/M) services related to hormonal contraceptives provided by IHCP-enrolled pharmacists, as outlined in Indiana Code IC 25-26-25. 

Finally in Indiana, the Office of Medicaid Policy and Planning is seeking applicants to serve on the Medicaid Advisory Committee which provides feedback on the program policies and proposed policies that ensure the program is responsive to concerns as well as providing transparency and accountability.  

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2025-06-26T14:35:46-04:00June 26, 2025|Indiana|

Kansas

Gov. Laura Kelly (D) appointed two new pharmacists members to the Board of Pharmacy, Joanna Robinson, PharmD, MS, BCSCP, and Janine Ohler, PharmD, BCPS. They will each serve a four-year term and are replacing Jonathan Brunswig, PharmD, and William Walden, RPh, both of whom served eight years on the board. 

Also in Kansas, SB 63 which became law earlier this year on February 20, requires in Section 4 that "if a healthcare provider violates the provisions of Section 3 of the law, the healthcare provider has engaged in unprofessional conduct and, notwithstanding any provision of law to the contrary, the license of such healthcare provider shall be revoked by the appropriate licensing entity or disciplinary review board with competent jurisdiction in this state". 

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2025-06-26T14:35:18-04:00June 26, 2025|Kansas|

Louisiana

Gov. Jeff Landry (R) urged lawmakers during the final week of the session to amend HB 358, permitting a pharmacy technician to work remotely by Rep. Dustin Miller (R). The Governor wanted to include an amendment prohibiting PBMs from owning pharmacies. While the House quickly concurred with the Governor's language, the Senate declined to bring the bill up for a final vote on the last day of the session on June 12. Gov. Landry pledged to convene a special session this summer to encourage legislators to lower drug prices and help preserve independent pharmacies. Attorney General Liz Murrill (R) sent CVS a cease-and-desist order to prevent pharmacy benefit managers (PBMs) from lobbying customers about pending legislation and issued a statement saying she would investigate whether the text messages about the bill were appropriate. 

Also in Louisiana, lawmakers passed and sent to Gov. Landry for approval HB 264 by Rep. Michael Echols (R), prohibiting PBMs from engaging in spread pricing, patient steering and the use of effective rate pricing. The bill applies to local pharmacies only, defined as those with ownership in Louisiana of 10 or fewer pharmacies. The bill also establishes a reimbursement floor using NADAC, enhances transparency and audit protections, passes through manufacturer rebates to consumers, and grants additional enforcement authority to the Insurance Commissioner. Lastly, the proposed law modifies the composition of the Pharmacy Benefit Monitoring Advisory Council and adds a chain pharmacist appointed by the Louisiana Alliance of Retail Pharmacies (LARP). 

Also in Louisiana, Gov. Jeff Landry (R) signed HB 565 by Rep. Annie Spell (R), legislation prohibiting Medicaid managed care organizations (MCOs) from amending, modifying, or changing a claim submitted by a healthcare provider or adjusting, down coding or paying a claim at a lower level than what was submitted by the healthcare provider. To the extent MCOs violate these provisions, the Louisiana Department of Health (LDH) shall withhold payment to the MCO an amount to be determined by LDH not less than $25,000 or greater for each violation. 

Also in Louisiana, HB 690 by Rep. Charles Owens (R), requiring the state surgeon general to promulgate rules for the administration of Emergency Use Authorizations (EUA) related medical activities by all members of the healthcare community, including hospitals, public and private clinics, pharmacies, nursing homes and other entities involved in healthcare activities where EUA may apply, was sent to Gov. Jeff Landry (R). 

Also in Louisiana, House Resolution 314 by Rep. Rodney Lyons (D) requesting that the Louisiana Department of Health (LDH) provide access to vaccines and information on the diseases they prevent to areas of need, passed the House and was sent to the Secretary of State. 

Finally in Louisiana, the Department of Health published two rules in the June Register 

  • The emergency drug kit (EDK) permit removes the requirement for the administrator of the applicant facility to sign the application for the EDK permit, and requires the online permit verification to be readily retrievable, since the board no longer issues paper permits. 
  • The Pharmacist-in-Charge (PIC) change reduces the minimum experience requirement for a pharmacist to qualify for a PIC privilege from two years of active pharmacy practice to one year. It also adds the authority and accountability of the owner of the pharmacy permit to the existing responsibility of the PIC for the complete supervision, management and compliance with laws and regulations pertaining to the practice of pharmacy of the entire prescription department. 

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2025-06-26T14:34:50-04:00June 26, 2025|Louisiana|
Go to Top